GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | Hui‐min Zhang, Han‐ning Li, Enbo Qi, Yang Yang, Huiping Ma, Jie Ma, Xiwen Xiong, Jun Wang, Zhi‐fang Yang, Xing‐hua Liao |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
MCM8 promotes gastric cancer progression through RPS15A and predicts poor prognosis
di: Lixian Ding, et al.
Pubblicazione: (2024)
di: Lixian Ding, et al.
Pubblicazione: (2024)
Danshensu Ethyl Ester Induces Ferroptosis Through Targeted Inhibition of SLC7A11 Transport Function in NSCLC
di: Rui Yan, et al.
Pubblicazione: (2026)
di: Rui Yan, et al.
Pubblicazione: (2026)
RNF135 Promotes Human Osteosarcoma Cell Growth and Inhibits Apoptosis by Upregulating the PI3K/AKT Pathway
di: Bingyao Chen, et al.
Pubblicazione: (2024)
di: Bingyao Chen, et al.
Pubblicazione: (2024)
CaMKII Exacerbates Doxorubicin‐Induced Cardiotoxicity by Promoting Ubiquitination Through USP10 Inhibition
di: Yitong Yang, et al.
Pubblicazione: (2024)
di: Yitong Yang, et al.
Pubblicazione: (2024)
Correction to “Mitogen‐Activated Protein Kinase Inhibition Augments the T Cell Response Against HOXB7 ‐Expressing Tumor Through Human Leukocyte Antigen Upregulation”
Pubblicazione: (2025)
Pubblicazione: (2025)
CALR / HIF ‐1α Positive Feedback Loop Drives CALR Upregulation to Promote EMT ‐Mediated Bladder Cancer Progression via ROS / AKT Axis
di: Xintao Tian, et al.
Pubblicazione: (2026)
di: Xintao Tian, et al.
Pubblicazione: (2026)
PSMD14/E2F1 Axis‐Mediated CENPF Promotes the Metastasis of Triple‐Negative Breast Cancer Through Inhibiting Ferroptosis
di: Meifeng Zhou, et al.
Pubblicazione: (2025)
di: Meifeng Zhou, et al.
Pubblicazione: (2025)
Epigenetically‐Upregulated CD98 Shed Light on the Precancerous Diagnosis and Prognosis Prediction of Esophageal Cancer
di: Xue Zhang, et al.
Pubblicazione: (2025)
di: Xue Zhang, et al.
Pubblicazione: (2025)
FKBP9 Enhances Colon Cancer Cell Proliferation by Inhibiting GPX4 ‐Mediated Ferroptosis
di: Jianzhong Deng, et al.
Pubblicazione: (2026)
di: Jianzhong Deng, et al.
Pubblicazione: (2026)
Establishment of a Prognostic Risk Score Model Based on Bioinformatics for Ferroptosis and Cuproptosis‐Related Genes in Gastric Cancer
di: Yang Shaokang, et al.
Pubblicazione: (2025)
di: Yang Shaokang, et al.
Pubblicazione: (2025)
Haoya Wang Et Al.: Circadian Rhythm Disruption Promotes Tumor Progression Through Upregulated Glycolysis
di: Haoya Wang, et al.
Pubblicazione: (2025)
di: Haoya Wang, et al.
Pubblicazione: (2025)
KRAB Zinc‐Finger Protein ZNF205 Promotes Hepatocellular Carcinoma via p53 Pathway Repression
di: Xiaofen Huang, et al.
Pubblicazione: (2026)
di: Xiaofen Huang, et al.
Pubblicazione: (2026)
Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma
di: Ruimeng Yang, et al.
Pubblicazione: (2025)
di: Ruimeng Yang, et al.
Pubblicazione: (2025)
p53 Deficiency in Colon Cancer Cells Promotes Tumor Progression Through the Modulation of Meflin in Fibroblasts
di: Eiji Kimura, et al.
Pubblicazione: (2025)
di: Eiji Kimura, et al.
Pubblicazione: (2025)
Ubiquitin‐Specific Protease 45 Inhibits Lung Adenocarcinoma Ferroptosis by Regulating Ubiquitination and Stability of Glutathione Peroxidase 4
di: Mingxiang Huang, et al.
Pubblicazione: (2026)
di: Mingxiang Huang, et al.
Pubblicazione: (2026)
Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway
di: Yu Cen, et al.
Pubblicazione: (2025)
di: Yu Cen, et al.
Pubblicazione: (2025)
High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to the PI3K/Akt pathway through targeted inhibition of TPX2 in endometrial cancer
di: Mei Yang, et al.
Pubblicazione: (2024)
di: Mei Yang, et al.
Pubblicazione: (2024)
Early identification of TP53 mutations and TP53 allelic state in myelodysplastic neoplasms and acute myeloid leukemia via point‐of‐care p53 immunohistochemistry
di: Shyam A. Patel, et al.
Pubblicazione: (2025)
di: Shyam A. Patel, et al.
Pubblicazione: (2025)
A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022
di: Yupeng Xi, et al.
Pubblicazione: (2024)
di: Yupeng Xi, et al.
Pubblicazione: (2024)
SNAPIN Facilitates Progression of Hepatocellular Carcinoma by Hindering Ferroptosis Through KEAP1 Degradation Promotion
di: Xuan Liu, et al.
Pubblicazione: (2025)
di: Xuan Liu, et al.
Pubblicazione: (2025)
The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B‐Cell Lymphoma
di: Zhenhan Zhu, et al.
Pubblicazione: (2024)
di: Zhenhan Zhu, et al.
Pubblicazione: (2024)
O‐ GlcNAcylation of KAT2A Enhances Bladder Cancer Proliferation by Inhibiting the KAT2A ‐ TRIM22 Interaction
di: Wenjie Yang, et al.
Pubblicazione: (2026)
di: Wenjie Yang, et al.
Pubblicazione: (2026)
A Mutual Interaction Between GSTP1 and p53 Improves the Drug Resistance and Malignant Biology of Pancreatic Cancer
di: Guosen Wang, et al.
Pubblicazione: (2025)
di: Guosen Wang, et al.
Pubblicazione: (2025)
The role of body composition in the development of diabetes mellitus among childhood cancer survivors, and novel intervention strategies to mitigate diabetes risk
di: Rusha Bhandari, et al.
Pubblicazione: (2025)
di: Rusha Bhandari, et al.
Pubblicazione: (2025)
Identification of Potential Ferroptosis Biomarkers in Multiple Myeloma via WGCNA and Experiments
di: Yifan Wang, et al.
Pubblicazione: (2025)
di: Yifan Wang, et al.
Pubblicazione: (2025)
Translational Inhibition of Slug by Pdcd4 Contributes to Invasion Inhibition in Colorectal Cancer Cells
di: Qing Wang, et al.
Pubblicazione: (2025)
di: Qing Wang, et al.
Pubblicazione: (2025)
Activation of cGAS ‐ STING Pathway by DAI ‐Triggered Ferroptosis in CRC Cells Reprograms TAMs Balance to Promote Anti‐Tumor Immunity
di: Pengrui Cheng, et al.
Pubblicazione: (2025)
di: Pengrui Cheng, et al.
Pubblicazione: (2025)
NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway
di: Qi Sun, et al.
Pubblicazione: (2025)
di: Qi Sun, et al.
Pubblicazione: (2025)
A Novel Targeted Sequence for Chromosome 11p15.5 Maternal Loss in SDHD ‐Related Paragangliomas
di: Huei‐Pin Lai, et al.
Pubblicazione: (2026)
di: Huei‐Pin Lai, et al.
Pubblicazione: (2026)
Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR‐378a‐3p/VEGFA/RGC‐32 Axis
di: Jinli He, et al.
Pubblicazione: (2024)
di: Jinli He, et al.
Pubblicazione: (2024)
Mutant p53 Regulates Pyruvate Dehydrogenase Kinase 1 ( PDK1 ) to Promote Proliferation and Migration in Breast Cancer
di: Yan Ye, et al.
Pubblicazione: (2025)
di: Yan Ye, et al.
Pubblicazione: (2025)
Arteannuin B Inhibits NSCLC Cells via Regulating miR ‐194‐3p/ CLDN2 Axis
di: Ting‐Sha He, et al.
Pubblicazione: (2026)
di: Ting‐Sha He, et al.
Pubblicazione: (2026)
Somatic mutations in a multigene panel and impact on prognosis based on TP53 status in Chinese HER2‐positive patients undergoing neoadjuvant therapy: A single‐institution retrospective cohort
di: Min Xiong, et al.
Pubblicazione: (2024)
di: Min Xiong, et al.
Pubblicazione: (2024)
Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database
di: Heng Chen, et al.
Pubblicazione: (2024)
di: Heng Chen, et al.
Pubblicazione: (2024)
Diosmetin Inhibits NETs Formation in Neutrophils Through Regulating Nrf2 Signaling
di: Lijuan Guo, et al.
Pubblicazione: (2025)
di: Lijuan Guo, et al.
Pubblicazione: (2025)
Impact of sarcopenia on the prognosis of patients with advanced non‐small cell lung cancer treated with antiangiogenic therapy: A propensity score matching analysis
di: Fuchun Huang, et al.
Pubblicazione: (2024)
di: Fuchun Huang, et al.
Pubblicazione: (2024)
Aspartate Transporter SLC1A3 Promotes Colorectal Cancer via MDM2‐p53 Pathway and M2 Macrophage Polarization
di: Chao Deng, et al.
Pubblicazione: (2026)
di: Chao Deng, et al.
Pubblicazione: (2026)
MicroRNA Let‐7b‐5p Targets IGF1R to Inhibit the Progression of Hepatocellular Carcinoma Through the AKT/mTOR Pathway
di: Jiaojiao Liang, et al.
Pubblicazione: (2025)
di: Jiaojiao Liang, et al.
Pubblicazione: (2025)
Development and validation of a machine‐learning–based pathomics nomogram for predicting recurrence of localized primary gastrointestinal stromal tumors after complete surgical resection: A retrospective multicenter study
di: Xudong Qiu, et al.
Pubblicazione: (2025)
di: Xudong Qiu, et al.
Pubblicazione: (2025)
Dauricine Overcomes Osimertinib Resistance in Lung Cancer by Inducing Ferroptosis via Stabilizing SAT1
di: Biying Men, et al.
Pubblicazione: (2025)
di: Biying Men, et al.
Pubblicazione: (2025)
Documenti analoghi
-
MCM8 promotes gastric cancer progression through RPS15A and predicts poor prognosis
di: Lixian Ding, et al.
Pubblicazione: (2024) -
Danshensu Ethyl Ester Induces Ferroptosis Through Targeted Inhibition of SLC7A11 Transport Function in NSCLC
di: Rui Yan, et al.
Pubblicazione: (2026) -
RNF135 Promotes Human Osteosarcoma Cell Growth and Inhibits Apoptosis by Upregulating the PI3K/AKT Pathway
di: Bingyao Chen, et al.
Pubblicazione: (2024) -
CaMKII Exacerbates Doxorubicin‐Induced Cardiotoxicity by Promoting Ubiquitination Through USP10 Inhibition
di: Yitong Yang, et al.
Pubblicazione: (2024) -
Correction to “Mitogen‐Activated Protein Kinase Inhibition Augments the T Cell Response Against HOXB7 ‐Expressing Tumor Through Human Leukocyte Antigen Upregulation”
Pubblicazione: (2025)